How can nanotechnology help membrane vesicle-based cancer immunotherapy development?

Xin Tian; Motao Zhu; Guangjun Nie

doi:10.4161/hv.22130

How can nanotechnology help membrane vesicle-based cancer immunotherapy development?

Xin Tian, Motao Zhu, Guangjun Nie

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	222-225
Number of pages	4
Journal	Human Vaccines and Immunotherapeutics
Volume	9
Issue number	1
DOIs	https://doi.org/10.4161/hv.22130
State	Published - Jan 2013

Keywords

Cancer vaccine
Dendritic cell
Exosome
Immunotherapy
Nanotechnology

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Pharmacology

Access to Document

10.4161/hv.22130

Cite this

@article{b1520192581c4a91b14a835f5276cbdf,

title = "How can nanotechnology help membrane vesicle-based cancer immunotherapy development?",

keywords = "Cancer vaccine, Dendritic cell, Exosome, Immunotherapy, Nanotechnology",

author = "Xin Tian and Motao Zhu and Guangjun Nie",

note = "Funding Information: This work was supported by the National Basic Research Program of China (973 Program 2012CB934000) and NSFC (31100721, 30900278, 10979011).",

year = "2013",

month = jan,

doi = "10.4161/hv.22130",

language = "English (US)",

volume = "9",

pages = "222--225",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",